Katie De Wagter is with Johnson & Johnson Pharmaceutical Research & Development, 2340 Beerse, Belgium.
In this article, the role of a triple-quadrupole mass spectrometer in performing in vitro studies of compound metabolic stability and identification of Phase I and II metabolites is demonstrated.